Atara receives first drug approval
Thousand Oaks-based Atara Biotherapeutics announced on Dec. 19 that the European Commission has approved its drug, Ebvallo. Ebvallo, also known as tabelecleucel, has been Atara’s main product development in its pipeline since 2015. It is the first time Atara has received approval for one of its treatments. The drug is a monotherapy for the treatment Read More →
Amgen buys Horizon Therapeutics for $27B
By Jorge Mercado Senior Staff Writer Thousand Oaks-based Amgen has announced its largest acquisition in company history, $27 billion for Horizon Therapeutics, positioning itself with a pipeline of treatments that could pay dividends over the coming decades. Amgen, one of the largest biotechnology companies in the world, beat out competition from Sanofi and Johnson and Read More →
Dantari raises $47M to target cancers and rare diseases
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
The sound of going green
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
<strong>Failure to report</strong>
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen buys Horizon Therapeutics for $27B in cash
Thousand Oaks-based Amgen today announced its largest acquisition in company history, $27 billion for Horizon Therapeutics, positioning itself with a pipeline of treatments that could pay dividends over the coming decades. Amgen, one of the largest biotechnology companies in the world, beat out competition from Sanofi and Johnson and Johnson, both of whom bowed out Read More →
